Perkins, Douglas Jay
- University of New Mexico Health Sciences Center · Internal Medicine (NIH department code)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #14,553
- Rising Star
- R01 Holder
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2007 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2023 award categories
- Internal Medicine
NIH Funding · FY2023
Linked Award Amount
$757.2K
Full award amounts, FY2023
Award Records
1
Records listing this PI
Award-Linked Rank
#14,553
By linked amount among FY2023 PIs
Earliest Year Loaded
2007
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Perkins, Douglas Jay as a PI. Multi-PI records show the full award amount for context.
- 5R01AI160662-03R01Contact PITemporal Transcriptomics in Hospitalized COVID-19 Patients from Disparately Impacted Ancestral Groups for Therapeutic DiscoveryUniversity of New Mexico Health Sciences Center · Internal Medicine (NIH department code)$757.2Kaward amount
Award organization
Organizations that administered FY2023 awards listing Perkins, Douglas Jay as a PI.
FY2023 award administered by University of New Mexico Health Sciences Center (NM).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2007First NIH AwardUniversity of New Mexico Health Sciences Center
- 2007$500K Cumulative Funding
- 2008$1M Cumulative Funding
- 2008Entered Top 50% NationallyRanked #9196
- 2009$2M Cumulative Funding
- 2013R01 Grant Holder
- 2017$5M Cumulative Funding
- 2020Entered Top 25% NationallyRanked #3039
- 2021$10M Cumulative Funding